KLRS
Kalaris Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$8.67
-0.50 ▼ -5.45%
🌙 3월 13일 4:10 PM ET (한국 3/14 05:10)
$8.67
+0.00 +0.00%
| Index | - | P/E | - | EPS (ttm) | -7.4 | Insider Own | 82.47% | Shs Outstand | 0.02B | Perf Week | -11.71% |
| Market Cap | 0.15B | Forward P/E | - | EPS next Y | 27.27% | Insider Trans | 3.6% | Shs Float | 0.00B | Perf Month | -10.06% |
| Enterprise Value | 0.07B | PEG | - | EPS next Q | -0.53 | Inst Own | 23.91% | Short Float | 27.34% | Perf Quarter | 14.53% |
| Income | -0.05B | P/S | - | EPS this Y | 29.25% | Inst Trans | 18.05% | Short Ratio | 9.55 | Perf Half Y | 102.57% |
| Sales | 0.00B | P/B | 3.87 | EPS next 5Y | 13.42% | ROA | -50.77% | Short Interest | 0.90M | Perf YTD | 2.73% |
| Book/sh | 2.24 | P/C | 1.88 | EPS past 3/5Y | 42.89% -6.86% | ROE | -63.45% | 52W High | -32.79% ($12.90) | Perf Year | -4.93% |
| Cash/sh | 4.6 | P/FCF | - | Sales past 3/5Y | - | ROIC | -120.16% | 52W Low | 305.14% ($2.14) | Perf 3Y | -91.98% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 63.31% | Gross Margin | - | Volatility(W/M) | 8.1% 10.69% | Perf 5Y | -98.75% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.9 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 12.89 | EPS Q/Q | 22.66% | Profit Margin | - | RSI (14) | 41.38 | Recom | 1.33 |
| Dividend Gr. 3/5Y | - | Current Ratio | 12.89 | Sales Q/Q | - | SMA20 | -11.96% ($9.85) | Beta | -0.01 | Target Price | $18.6 |
| Payout | - | Debt/Eq | 0.04 | Earnings | 2026/02/18 | SMA50 | -7.86% ($9.41) | Rel Volume | 0.35 | Prev Close | $9.17 |
| Employees | 6 | LT Debt/Eq | 0.03 | EPS/Sales Surpr. | 1.59% - | SMA200 | 51.17% ($5.74) | Avg Volume(3M) | 0.09M | Price | $8.67 |
| IPO | 2020/7/30 | Option/Short | No/Yes | Trades | 699 | Volume | 32,467 | Change | -5.45% |
뉴스 로딩 중...